SCHEMBL3026352

SCHEMBL3026352

NNC(=O)C1C(=O)N(CCC2CCCCC2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 5/20 0.45
PPARG P37231 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
EGFR P00533 1/20 0.39
ALDH1A1 P00352 3/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
KCNH2 Q12809 1/20 0.38
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2823271 0.78 ALDH1A1 (0.59) CCKBRMEN1KMT2ALMNAGAA
SCHEMBL7099245 0.77 EGFR (0.40) MEN1KMT2ALMNAGAASMN1; SMN2
SCHEMBL3016301 0.76 CDC25A (0.60) MEN1KMT2AEGFRALDH1A1HSD17B10
SCHEMBL5669763 0.70 HDAC4 (0.43) MEN1KMT2ALMNAGAASMN1; SMN2
SCHEMBL14154017 0.68 HDAC4 (0.73) MEN1KMT2ALMNAGAASMN1; SMN2
SCHEMBL13749554 0.67 SMN1; SMN2 (0.53) SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL3026351 0.66 ACHE (0.46) GAAALDH1A1TP53
SCHEMBL3013723 0.65 CES1 (0.63) GAAALDH1A1TP53
SCHEMBL7236814 0.65 ALDH1A1 (0.40) MEN1KMT2ALMNAGAASMN1; SMN2
SCHEMBL4245809 0.65 ACHE (0.71) KMT2AGAAALDH1A1DRD3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180200225-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2018-07-19 US disclosed
US-20170231953-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CLEVELAND CLINIC FOUND (US) 2017-08-17 US disclosed
US-9656957-B2 Hydrazone modulators of cannabinoid receptors THE CLEVELAND CLINIC FOUNDATION (US) 2017-05-23 US disclosed
US-20150313874-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2015-11-05 US disclosed
US-9079854-B2 Hydrazone modulators of cannabinoid receptors THE CLEVELAND CLINIC FOUNDATION (US) 2015-07-14 US disclosed
US-20130184275-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2013-07-18 US disclosed
US-8309595-B2 Hydrazone modulators of cannabinoid receptors BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-11-13 US disclosed
US-20100197755-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170231953-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CNR1, CNR2, GPR18 CCKBR 67/4885PPARG 214/4885MEN1 4169/4885
US-20150313874-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CNR1, CNR2, GPR18 CCKBR 67/4885PPARG 214/4885MEN1 4169/4885
US-20100197755-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CNR1, CNR2, GPR18 CCKBR 67/4885PPARG 214/4885MEN1 4169/4885
US-20130184275-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CNR1, CNR2, GPR18 CCKBR 67/4885PPARG 214/4885MEN1 4169/4885
US-20180200225-A1 HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS CNR1, CNR2, GPR18 CCKBR 67/4885PPARG 214/4885MEN1 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.